Holen Sie sich die Stockscreener-App
1.55
0.64%
-0.01
Schlusskurs vom Vortag:
$1.56
Offen:
$1.56
24-Stunden-Volumen:
242.65K
Relative Volume:
0.77
Marktkapitalisierung:
$34.66M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.51M
KGV:
-1.1458
EPS:
-1.3528
Netto-Cashflow:
$-15.68M
1W Leistung:
-3.13%
1M Leistung:
-28.24%
6M Leistung:
-53.17%
1J Leistung:
-47.28%
1-Tages-Spanne:
$1.52
$1.65
1-Wochen-Bereich:
$1.50
$1.65
52-Wochen-Spanne:
$1.45
$8.94
Medicus Pharma Ltd Stock (MDCX) Company Profile
Firmenname
Medicus Pharma Ltd
Sektor
Telefon
610-540-7515
Adresse
300 CONSHOHOCKEN STATE RD., W. CONSHOHOCKEN
Vergleichen Sie MDCX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDCX
Medicus Pharma Ltd
|
1.55 | 34.88M | 0 | -16.51M | -15.68M | -1.3528 |
|
LLY
Lilly Eli Co
|
1,063.56 | 971.27B | 59.42B | 18.41B | 6.44B | 20.22 |
|
JNJ
Johnson Johnson
|
204.39 | 495.71B | 92.15B | 25.12B | 20.46B | 10.36 |
|
ABBV
Abbvie Inc
|
220.08 | 396.12B | 59.64B | 2.36B | 19.68B | 1.3253 |
|
MRK
Merck Co Inc
|
110.53 | 275.48B | 63.90B | 19.05B | 13.05B | 7.5596 |
|
NVS
Novartis Ag Adr
|
141.54 | 271.43B | 54.45B | 14.42B | 17.15B | 7.333 |
Medicus Pharma Ltd Aktie (MDCX) Neueste Nachrichten
Is Medicus Pharma Ltd. Equity Warrant stock dividend yield sustainableMarket Risk Analysis & Technical Buy Zone Confirmation - ulpravda.ru
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Lansing State Journal
Is Medicus Pharma Ltd. stock safe for conservative investorsCushioning Options Review & stability guidance for smoother miles - ulpravda.ru
Why Medicus Pharma Ltd. stock could rally in 2025GDP Growth & Short-Term High Return Strategies - ulpravda.ru
Why Medicus Pharma Ltd. (N460) stock stays undervalued2025 Top Gainers & Long-Term Investment Growth Plans - ulpravda.ru
MACD Signal: Is Medicus Pharma Ltd. stock overvalued by current metricsJuly 2025 Trends & Daily Stock Trend Reports - ulpravda.ru
Is Medicus Pharma Ltd. stock overvalued by current metricsMarket Sentiment Report & Smart Investment Allocation Insights - ulpravda.ru
Why Medicus Pharma Ltd. Equity Warrant stock is popular among millennialsQuarterly Trade Review & Trade Opportunity Analysis Reports - ulpravda.ru
Will Medicus Pharma Ltd. Equity Warrant stock pay special dividends2025 Pullback Review & Growth Focused Stock Pick Reports - ulpravda.ru
Why retail investors pile into Medicus Pharma Ltd. Equity Warrant stockBear Alert & Accurate Entry/Exit Alerts - ulpravda.ru
Can Medicus Pharma Ltd. stock double in next 5 years2025 Analyst Calls & Verified Trade Idea Suggestions - ulpravda.ru
Is Medicus Pharma Ltd. Equity Warrant stock positioned for long term growthJuly 2025 Setups & Fast Momentum Entry Tips - ulpravda.ru
What insider trading reveals about Medicus Pharma Ltd. stock2025 Sector Review & Reliable Price Breakout Signals - ulpravda.ru
Will Medicus Pharma Ltd. Equity Warrant stock see PE expansionRate Cut & Weekly Stock Breakout Alerts - ulpravda.ru
Medicus Pharma enters non-binding LOI with Reliant AI - MSN
Will Medicus Pharma Ltd. stock deliver better than expected guidanceGeopolitical Risk Analysis & Turn Data into Profits With Our Strategies - ulpravda.ru
How supply chain issues affect Medicus Pharma Ltd. stockRelative Strength Index (RSI) & Learn What Analysts Rate “Strong Buy” - ulpravda.ru
Why Medicus Pharma Ltd. stock could see breakout soonResistance Zone Identification & Small Budget Investment Tips - ulpravda.ru
2026 world cup world class players analysis: Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trends2026 world cup usa national team quarterfinals key players low block defense expert forecast expert opinion - ulpravda.ru
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Central New Jersey News
Medicus Pharma ramps up partnering push as Phase 2 SkinJect data nears - MSN
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025FDL Reporter | The Reporter - fdlreporter.com
Medicus Pharma to present phase 2 data at Biotech Showcase 2026 - Investing.com Nigeria
Why Medicus Pharma Ltd. stock could benefit from AI revolutionTrade Risk Report & Expert Verified Movement Alerts - ulpravda.ru
Medicus Pharma to highlight multiple Phase 2 catalysts at Biotech Showcase 2026 - Proactive financial news
Medicus Pharma Ramps Up Partnering Push as Phase 2 SkinJect Data Nears - TipRanks
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as SkinJect Phase 2 Clinical Data Approaches Readout and Partnering Readiness Accelerates - The Manila Times
Medicus Pharma Ltd. to Present at Biotech Showcase 2026 as - GlobeNewswire
Setup Watch: Can Medicus Pharma Ltd stock double in next 5 yearsWeekly Earnings Recap & Reliable Momentum Entry Alerts - moha.gov.vn
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights - Victorville Daily Press
Medicus Pharma Ltd. Announces Collaboration with the Gorlin Syndrome Alliance to Pursue Compassionate Use Pathway for Skinject(TM) in Patients with Gorlin Syndrome - The Coloradoan
Dated alerts on Medicus Pharma withdrawn - marketscreener.com
What drives Medicus Pharma Ltd stock priceResistance Breakout Alerts & Test Our Stock Screener — Free Forever - earlytimes.in
Medicus Pharma enters equity distribution agreement for up to $15.3 million By Investing.com - Investing.com Australia
Medicus Pharma enters equity distribution agreement for up to $15.3 million - Investing.com Nigeria
Medicus Pharma Launches At-the-Market Equity Offering Program - TipRanks
Medicus Pharma Signs Equity Distribution Agreement With Maxim Group and Yorkville Securities - TradingView — Track All Markets
Medicus Pharma to offer securities worth up to $100 millionSEC filing - MarketScreener
Finanzdaten der Medicus Pharma Ltd-Aktie (MDCX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Medicus Pharma Ltd-Aktie (MDCX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| VELOCITY FUND PARTNERS, LP | 10% Owner |
May 20 '25 |
Sale |
7.72 |
75,000 |
578,940 |
3,248,741 |
1.87%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):